Back
Addex Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
ADXN
Sponsored
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
21
ADXN
Addex Therapeutics
Last Price:
8.30
Seasonality Move:
34.06%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE TradeAddex Therapeutics Price Quote
$8.30
-0.33 (-3.82%)
(Updated: November 14, 2024 at 12:10 PM ET)
Addex Therapeutics Key Stats
Sell
21
Addex Therapeutics (ADXN)
is a Sell
Day range:
$8.59 - $9.89
52-week range:
$5.00 - $27.90
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.22
P/B ratio:
0.66%
Volume:
128.6K
Avg. volume:
41.3K
1-year change:
59.52%
Market cap:
$9.2M
Revenue:
$1.8M
EPS:
$-1.64
How Much Does Addex Therapeutics Make?
-
How Much Are Addex Therapeutics's Sales Annually?
ADXN Revenues are $1.8M -
How Much Profit Does Addex Therapeutics's Make A Year?
ADXN net income is -$11.8M
Is Addex Therapeutics Growing As A Company?
-
What Is Addex Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.82% -
What Is Addex Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Addex Therapeutics Stock Price Performance
-
Did Addex Therapeutics Stock Go Up Last Month?
Addex Therapeutics share price went down by -15.89% last month -
Did ADXN's Share Price Rise Over The Last Year?
ADXN share price rose by 59.52% over the past 1 year
What Is Addex Therapeutics 52-Week High & Low?
-
What Is Addex Therapeutics’s 52-Week High Share Price?
Addex Therapeutics has traded as high as $27.90 over the past 52 weeks -
What Is Addex Therapeutics’s 52-Week Low Share Price?
Addex Therapeutics has traded as low as $5.00 over the past 52 weeks
Addex Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Addex Therapeutics?
-
How Much Debt Does Addex Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Addex Therapeutics Have?
Cash and short term investments quarterly total is $4.2M -
What Is Addex Therapeutics’s Book Value Per Share?
Book value per share is 13.17
Is Addex Therapeutics Cash Flow Positive?
-
What Is ADXN Cash Flow From Operations?
Cash flow from operations (TTM) is -$8.7M -
What Is Addex Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$151K -
What Is Addex Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $5.2M
Addex Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
ADXN return on invested capital is 90.28% -
What Is Addex Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is 54.9% -
What Is ADXN Return On Equity?
ROE is a measure of profitability and is 90.28%
Addex Therapeutics Earnings Date & Stock Price
-
What Is Addex Therapeutics's Stock Price Today?
A single share of ADXN can be purchased today for 8.63 -
What Is Addex Therapeutics’s Stock Symbol?
Addex Therapeutics trades on the nasdaq under the ticker symbol: ADXN -
When Is Addex Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Addex Therapeutics is scheduled on November 14, 2024 -
When Is ADXN's next ex-dividend date?
Addex Therapeutics's next ex-dividend date is November 14, 2024 -
How To Buy Addex Therapeutics Stock?
You can buy Addex Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Addex Therapeutics Competitors
-
Who Are Addex Therapeutics's Competitors?
Below is a list of companies who compete with Addex Therapeutics or are related in some way:
Addex Therapeutics Dividend Yield
-
What Is ADXN Dividend Yield?
Addex Therapeutics’s dividend yield currently is 0% -
What Is Addex Therapeutics’s Payout Ratio?
Addex Therapeutics’s payout ratio is 0% -
When Did Addex Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 14, 2024 -
What Is Addex Therapeutics’s Dividend Per Share?
Addex Therapeutics pays a dividend of $0.00 per share
Addex Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | -81.84% | -47.81% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 30.00 |
Upside from Last Price: | 247.62% |